Zepp Health Corporation (ZEPP)
NYSE: ZEPP · Real-Time Price · USD
4.840
-0.080 (-1.63%)
Sep 9, 2026, 10:26 AM EDT - Market open
Zepp Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 71 | 387 | 39 | 87 | 90 | 318 | |
Market Cap Growth | -91.04% | 892.88% | -55.02% | -3.98% | -71.60% | -56.69% |
Enterprise Value | 136 | 435 | 45 | 90 | 157 | 321 |
Last Close Price | 4.92 | 26.94 | 2.60 | 5.68 | 5.80 | 19.64 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 14.66 |
Forward PE | - | 14.00 | 14.00 | 11.83 | 8.54 | 6.96 |
PS Ratio | 0.26 | 1.50 | 0.21 | 0.25 | 0.15 | 0.32 |
PB Ratio | 0.42 | 1.80 | 0.15 | 0.25 | 0.23 | 0.69 |
P/TBV Ratio | 0.44 | 2.02 | 0.17 | 0.26 | 0.25 | 0.74 |
P/FCF Ratio | - | - | - | 2.11 | - | - |
P/OCF Ratio | - | - | - | 2.04 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.50 | 1.68 | 0.25 | 0.25 | 0.26 | 0.33 |
EV/EBITDA Ratio | - | - | - | - | - | 13.97 |
EV/EBIT Ratio | - | - | - | - | - | 21.68 |
EV/FCF Ratio | - | - | - | 2.19 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.73 | 0.55 | 0.48 | 0.37 | 0.47 | 0.41 |
Debt / EBITDA Ratio | - | - | - | - | - | 6.56 |
Debt / FCF Ratio | - | - | - | 3.14 | - | - |
Net Debt / Equity Ratio | 0.35 | 0.28 | 0.11 | -0.03 | 0.13 | -0.10 |
Net Debt / EBITDA Ratio | -2.12 | -2.44 | -0.67 | 0.44 | -0.95 | -1.97 |
Net Debt / FCF Ratio | - | -2.30 | -1.10 | -0.24 | -0.43 | 1.03 |
Asset Turnover | 0.50 | 0.47 | 0.31 | 0.50 | 0.75 | 1.04 |
Inventory Turnover | 2.38 | 2.47 | 1.59 | 2.24 | 3.01 | 4.01 |
Quick Ratio | 0.48 | 0.54 | 0.88 | 1.42 | 1.07 | 1.20 |
Current Ratio | 0.90 | 1.02 | 1.29 | 2.04 | 1.77 | 1.83 |
Return on Equity (ROE) | -21.23% | -17.15% | -25.04% | -8.38% | -10.64% | 4.84% |
Return on Assets (ROA) | -3.92% | -3.34% | -5.07% | -2.72% | -4.70% | 0.98% |
Return on Invested Capital (ROIC) | -13.37% | -10.52% | -15.15% | -7.78% | -14.44% | 4.61% |
Return on Capital Employed (ROCE) | -14.20% | -10.50% | -14.20% | -6.30% | -11.90% | 2.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -60.37% | -10.35% | -194.25% | -35.79% | -47.90% | 6.82% |
FCF Yield | -36.32% | -6.77% | -66.16% | 47.31% | -131.08% | -13.79% |
Buyback Yield / Dilution | 1.04% | 1.72% | -6.47% | 1.28% | 6.84% | -1.54% |